FindTrial
Sign In

To find out the Success and Outcome of Eye Injections for Diabetic Eye Swelling Using Routine Blood Tests and Eye Scan

Systemic Biomarkers as Predictors of Anatomical and Visual Response to Anti VEGF Therapy in Treatment Naive Diabetic Macular Edema study from a Tertiary Eye Care Center - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112007
Enrollment
138
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with type 2 diabetes with treatment na ve macular edema 2.All patients above 18 years will be included

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To determine the correlation between baseline HbA1c, Hemoglobin, and Total Leukocyte Count with the final Best Corrected Visual Acuity (BCVA) and Central Macular Thickness (CMT) outcomesTimepoint: 4 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVaddamani Vemsai Dhyanesh Reddy

Aravind eye Hospital Pondicherry

sivaranjani.s@aravind.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026